Why Advancing Inclusive Research Matters

Eligibility Questionnaire

We are looking for people dedicated to improving PPMS treatment for all. Please answer the questions below to see if you may be eligible for the FENtrepid Study.

Completing this questionnaire does not obligate you to participate in the study. Your answers will help determine if you may be eligible. If your answers indicate you may be eligible, you will have the opportunity to contact a clinic site near you to learn more about the study.

1. Have you been diagnosed with primary progressive multiple sclerosis?(Required)
3. Are you able to walk?(Required)
4. Have you ever been treated with Cytoxan (cyclophosphamide), Lemtrada (alemtuzumab), Mavenclad (cladribine), Novantrone (Mitoxantrone), or Zinbryta (daclizumab)?(Required)
5. Do any of the following apply to you? (check all that apply)(Required)